Parion Sciences, Inc.
Biotechnology · Health Care
Overview
Parion Sciences. Parion Sciences is a development stage company dedicated to research, development, and commercialization of therapies to restore the innate mucosal surface defense of the lung.
Funding and backers
Team
1-10
employees, estimated range
Grants
$2.5M
3 grants · CORDIS
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 15, 2025
Won a grant $2M · CORDIS
May 1, 2024
Won a grant $296k · CORDIS
Jan 27, 2020
Won a grant $274k · CORDIS
Funding rounds
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Lisata is a clinical-stage pharmaceutical company dedicated to improving lives through the discovery, development, and commercialization of…
0 Enable better lives through novel therapies to restore skeletal muscle health About NMD Pharma NMD Pharma is a clinical-stage biotech…
Imagine AI that thinks beyond today. Advancing AI research, development and commercialization.
Peroxitech is a privately held emerging biopharmaceutical company focused on the development and commercialization of a novel peptide for…
Cleara Biotech is a biopharmaceutical R&D company dedicated to discovery and development of therapies against cancer and chronic diseases.
G1 Therapeutics, Inc. is a commercial stage oncology company focused on the development and commercialization of next generation therapies…
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Durham
United States
HQ
1-10 est. staff